fda warning letters compounded semaglutide 2024 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility FDA ramps up its pushback

M., Meng, F

Before making any changes to your GLP-1 medication management, consider these factors: Current treatment response: If your injectable medication is working well, switching may not offer additional benefits Lifestyle compatibility: The empty stomach requirement and 30-minute waiting period requires consistent daily scheduling Cost considerations: Insurance coverage for the pill may differ from injectable coverage initially Other medications: The timing restrictions may complicate existing medication schedules Optimizing Your Results: Beyond the Medication Whether you choose oral or injectable GLP-1 treatment, medication alone isnt the complete picture

Statements Author contributions LZ: Writing original draft

You should call your doctor if you notice any of these side effects or develop other new or concerning symptoms